Cognition, schizophrénie et effet des antipsychotiques : le point de vue d’un laboratoire de recherche clinique
Tóm tắt
Từ khóa
Tài liệu tham khảo
Baddeley, 1986
Bilder, 2002, Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder, Am J Psychiatry, 159, 1018, 10.1176/appi.ajp.159.6.1018
Bymaster, 1997, In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug, J Clin Psychiatry, 58, 28
Chakos, 1995, Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine, Lancet, 345, 456, 10.1016/S0140-6736(95)90441-7
Fahim, 2002, Neural substrates of sadness in schizophrenia: an f MRI study International, J Psychophysiol, 45, 124
Galhofer, 1999, Cognitive dysfunction in schizophrenia: a new set of tools for the assessment of cognition and drug effects, Acta Psychiatr Scand, 395, 118, 10.1111/j.1600-0447.1999.tb05991.x
Geddes, 2000, Atypical anti-psychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis, Br Med J, 321, 1371, 10.1136/bmj.321.7273.1371
Goldberg, 1993, Learning and memory in monozygotic twins discordant for schizophrenia, Psychol Med, 23, 71, 10.1017/S0033291700038861
Goldberg, 1995, Thought disorder, working memory and attention: interrelationships and the effects of neuroleptic medications, Int Clin Psychopharmacol, 10, 99
Green, 2000, Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the «right stuff»?, Schizophr Bull, 26, 119, 10.1093/oxfordjournals.schbul.a033430
Green, 2002, The neurocognitive effects of low-dose halopéridol: a two-year comparison with risperidone, Biol Psychiatry, 51, 972, 10.1016/S0006-3223(02)01370-7
Green, 2004, Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria, Biol Psychiatry, 56, 301, 10.1016/j.biopsych.2004.06.023
Harvey, 2003, Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study, Psychopharmacology, 169, 404, 10.1007/s00213-002-1342-5
Hogarty, 2004, Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior, Arch Gen Psychiatry, 61, 866, 10.1001/archpsyc.61.9.866
Kasper, 2003, Cognitive effects and antipsychotic treatment, Psychoneuroendocrinology, 28, 27, 10.1016/S0306-4530(02)00115-4
Keefe, 2004, Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol, Am J Psychiatry, 161, 985, 10.1176/appi.ajp.161.6.985
Keefe, 1999, The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis, Schizophr Bull, 25, 201, 10.1093/oxfordjournals.schbul.a033374
Lecomte, 2001, Validation of a bio-psycho-social model of adaptation for people with schizophrenia The VIIIth International Congress on schizophrenia, Schizophr Res, 49, 263
Liddle, 1987, The symptoms of chronic schizophrenia A re-examination of the positive-negative dichotomy, Br J Psychiatry, 151, 145, 10.1192/bjp.151.2.145
Liddle, 1992, Patterns of cerebral blood flow in schizophrenia, Br J Psychiatry, 160, 179, 10.1192/bjp.160.2.179
Lussier, 2001, Memory and attention deficits in drug naive patients with schizophrenia, Schizophr Res, 48, 45, 10.1016/S0920-9964(00)00102-X
Manschreck, 1999, Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia, J Neuropsychiatr Clin Neurosci, 11, 481, 10.1176/jnp.11.4.481
Marder, 2004, Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia, Schizophr Res, 72, 5, 10.1016/j.schres.2004.09.010
Mc Gurk, 1999, The effects of clozapine on cognitive functioning in schizophrenia, J Clin Psychiatry, 60, 24
Meltzer, 1999, The role of serotonin in antipsychotic drug action, Neuropsychopharmacology, 2, 106S, 10.1016/S0893-133X(99)00046-9
Mendrek, 2004, Changes in distributed neural circuitry function in patients with first-episode schizophrenia, Br J Psychiatry, 185, 205, 10.1192/bjp.185.3.205
Prouteau, 2004, The crucial role of sustained attention in community functioning in outpatients with schizophrenia, Psychiatry Res, 129, 171, 10.1016/j.psychres.2004.07.005
Purdon, 1999, Cognitive improvement in schizophrenia with novel antipsychotic medications, Schizophr Res, 35, S51, 10.1016/S0920-9964(98)00166-2
Purdon, 2000, Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol The Canadian Collaborative Group for research in schizophrenia, Arch Gen Psychiatry, 57, 249, 10.1001/archpsyc.57.3.249
Purdon, 2003, Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol, Psychopharmacology (Berl), 169, 390, 10.1007/s00213-003-1505-z
Rivard, 2004, Assessment of daily activities in young adults with schizophrenia, Schizophr Res, 70, 102
Schotte, 1996, Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding, Psychopharmacology (Berl), 124, 57, 10.1007/BF02245606
Semkovska, 2004, Assessment of executive dysfunction during activities of daily living in schizophrenia, Schizophr Res, 69, 289, 10.1016/j.schres.2003.07.005
Semkovska, 2002, Behavioral disorganization in schizophrenia during a daily activity: the kitchen behavioral scoring scale, Brain Cogn, 48, 546, 10.1006/brcg.2001.1415
Sharma, 2002, Impact on cognition of the use of antipsychotics, Curr Med Res Opin, 18, S13, 10.1185/030079902125001074
Sharma, 2003, Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia, Psychopharmacology, 169, 398, 10.1007/s00213-003-1506-y
Squire, 1996, Structure and function of declarative and nondeclarative memory systems, Proc Natl Acad Sci USA, 93, 13515, 10.1073/pnas.93.24.13515
Stip, 2005, La schizophrénie
Stip, 2003, Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia, Compr Psychiatry, 44, 331, 10.1016/S0010-440X(03)00086-5
Stip, 2002, Does blunted affect in schizophrenia improve with quetiapine? A functional magnetic resonance imaging study, Int J Neuropsychopharmacol, 5, S72
Stip, 1996, The effect of risperidone on cognition in patients with schizophrenia, Can J Psychiatry, 41, S35, 10.1177/070674379604100802
Stip, 2003, A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine, J Clin Psychopharmacol, 23, 400, 10.1097/01.jcp.0000085414.08426.8f
Stip, 2004, Environmental cognitive remediation in schizophrenia: ethical implications of «Smart Home» technology, Can J Psychiatry, 15, 281, 10.1177/070674370505000509